Neutron Holdings, known as Lime, reported a 23% revenue increase in Q3 2026 but saw free cash flow drop 91% in the first nine months due to a 56% rise in capital expenditures. The company is expanding its fleet faster than its revenue and user growth, causing revenue per vehicle to fall nearly 5% in Q3. Management lowered the full-year adjusted EBITDA forecast by 7.6%, despite maintaining revenue guidance, highlighting rising profitability challenges. The business model's heavy capital demands and weak cash conversion raise concerns about future returns and potential downside risks.
Neutron Holdings, known as Lime, is the subject of this report. For readers following the Consumer Cyclical sector, here is Pluang's market snapshot as of Nov 06, 2026 02:11 WIB: out of 134 priced US stocks, 14 rose and 119 fell. Notable movers include Wayfair Inc (W) down 8.73% at USD 112.77 with 100% sell order activity, Carvana Co (CVNA) down 8.70% at USD 70.80 with 87% sell orders, and Figs Inc (FIGS) down 8.30% at USD 20.12 with 93% sell orders.
CRCAM Toulouse 31 announced the publication and filing of its financial information report for the quarter ending September 30, 2026. The report is accessible to the public on the company's website under the regulatory information section for 2026. T...
Scout Clean Energy has announced that its 183 MW Nimbus Wind Farm in Carroll County, Arkansas, is now commercially operational after two years of construction. The wind farm, the largest in Arkansas, generates enough electricity to power over 40,000 ...
Global tech giants like Amazon, Google, and Microsoft are committing hundreds of billions of dollars to expand AI-focused data center accelerators, driven by surging demand from generative AI workloads that exceed traditional CPU capabilities. These ...
Berkshire Hathaway's stock portfolio is now worth about three times what the company originally paid for it. These gains alone represent roughly 19% of Berkshire Hathaway's total company value, highlighting the significant growth and value generated ...
Madrigal Pharmaceuticals disclosed a whistleblower retaliation lawsuit filed by a former employee alleging concerns over company data and reporting. The company denies the allegations and plans to defend itself. Following the news, Madrigal's stock p...
